Novartis India Limited
Novartis India Limited is an Indian listed company in the Pharmaceuticals & Biotechnology industry (Healthcare sector), traded under NSE: NOVARTIND and BSE: 500672 (ISIN INE234A01025).
It has a market capitalisation of ₹4,743 crore, a last close of ₹1,922 on 2026-10-19, a one-year return of 185.8%.
Valuation: a price-to-earnings ratio of 50.90x, a price-to-book ratio of 5.80x, a dividend yield of 0.0%.
Profitability: return on equity of 11.6%, return on capital employed of 16.0%, an operating margin of 26.6%.
Growth: sales growth of -2.2% a year over three years, net profit growth of -3.4% a year over three years.
Balance sheet and ownership: debt-to-equity of 0.00x.
| Metric | Value |
|---|---|
| Market capitalisation | 4,743 |
| Last close | ₹1,922 |
| P/E (TTM) | 50.90x |
| P/B | 5.80x |
| Dividend yield | 0.0% |
| ROE (FY) | 11.6% |
| ROCE (FY) | 16.0% |
| Operating margin (TTM) | 26.6% |
| Sales growth, 3-year CAGR | -2.2% |
| Profit growth, 3-year CAGR | -3.4% |
| Debt / equity | 0.00x |
| 1-year return | 185.8% |
Loading the live page with the price chart, financial history, shareholding and recent filings. Data is end-of-day and rebuilt nightly; nothing here is investment advice. Financial statements · What each metric means